Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) EPS (Weighted Average and Diluted): 2021-2025

Historic EPS (Weighted Average and Diluted) for Benitec Biopharma (BNTC) over the last 5 years, with Jun 2025 value amounting to -$1.05.

  • Benitec Biopharma's EPS (Weighted Average and Diluted) fell 90.91% to -$0.21 in Q2 2025 from the same period last year, while for Jun 2025 it was -$1.03, marking a year-over-year increase of 82.92%. This contributed to the annual value of -$1.05 for FY2025, which is 13.93% up from last year.
  • Benitec Biopharma's EPS (Weighted Average and Diluted) amounted to -$1.05 in FY2025, which was up 13.93% from -$1.22 recorded in FY2024.
  • Benitec Biopharma's 5-year EPS (Weighted Average and Diluted) high stood at -$1.05 for FY2025, and its period low was -$37.88 during FY2022.
  • Over the past 3 years, Benitec Biopharma's median EPS (Weighted Average and Diluted) value was -$1.22 (recorded in 2024), while the average stood at -$5.46.
  • As far as peak fluctuations go, Benitec Biopharma's EPS (Weighted Average and Diluted) plummeted by 1,072.76% in 2022, and later soared by 91.36% in 2024.
  • Over the past 5 years, Benitec Biopharma's EPS (Weighted Average and Diluted) (Yearly) stood at -$3.23 in 2021, then plummeted by 1,072.76% to -$37.88 in 2022, then surged by 62.72% to -$14.12 in 2023, then soared by 91.36% to -$1.22 in 2024, then climbed by 13.93% to -$1.05 in 2025.